Applied DNA Sciences, Inc., based in Stony Brook, New York, specializes in producing and detecting DNA, employing 53 people and going public in 2001. The company develops PCR-based diagnostics for COVID-19 and uses its LinearDNA platform for DNA production in various markets, including in vitro diagnostics and anti-counterfeiting.
APDN has been in the news recently: Applied DNA Sciences will supply its CertainT platform to Indus for year-round cotton tagging in Pakistan, Egypt, and Jordan, improving traceability and compliance with the UFLPA. Additionally, the company will present its Linea™ IVT platform at the mRNA-based Therapeutics Summit on July 30, 2024, which focuses on reducing dsRNA contamination in mRNA production.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
